Antimicrobial Resistance — MCQs

Antimicrobial Resistance Indian Medical PG Practice Questions and MCQs

Question 51: Which of the following antimicrobial agents does not inhibit cell wall synthesis?

A. Lincomycin (Correct Answer)
B. Penicillin
C. Cephalexin
D. Ampicillin

Explanation: **Explanation:** The correct answer is **Lincomycin**. To answer this question, one must distinguish between antibiotics that target the bacterial cell wall and those that target protein synthesis. **1. Why Lincomycin is the correct answer:** Lincomycin belongs to the **Lincosamide** class (along with Clindamycin). Its mechanism of action is the inhibition of bacterial protein synthesis by binding to the **50S ribosomal subunit**. It interferes with the transpeptidation reaction, thereby preventing peptide chain elongation. It does not have any direct effect on peptidoglycan synthesis. **2. Why the other options are incorrect:** * **Penicillin, Ampicillin, and Cephalexin** are all **Beta-lactam antibiotics**. * **Mechanism:** They act by binding to **Penicillin-Binding Proteins (PBPs)**, which are enzymes (transpeptidases) essential for cross-linking the peptidoglycan layers of the bacterial cell wall. * By inhibiting these enzymes, they prevent the final stage of cell wall assembly, leading to bacterial lysis (bactericidal action). **High-Yield Clinical Pearls for NEET-PG:** * **Cell Wall Inhibitors (Mnemonic: "V-BACP"):** **V**ancomycin, **B**eta-lactams (Penicillins, Cephalosporins, Carbapenems, Monobactams), **A**ctinomycin, **C**ycloserine, **P**re-murein inhibitors (Bacitracin, Fosfomycin). * **Protein Synthesis Inhibitors:** * **30S subunit:** Aminoglycosides (cidal), Tetracyclines (static). * **50S subunit:** Chloramphenicol, Erythromycin (Macrolides), **Lincosamides**, Linezolid. * **Lincosamide Fact:** Clindamycin is the most common antibiotic associated with *Clostridioides difficile*-associated diarrhea (Pseudomembranous colitis).

Question 52: True about methicillin-resistant Staphylococcus aureus (MRSA)?

A. Isoxazolyl penicillin is highly effective
B. All MRSA are multidrug resistant (Correct Answer)
C. Vancomycin is effective
D. MRSA are more virulent than sensitive strains

Explanation: **Explanation:** **1. Why the correct answer is right:** MRSA is defined by the presence of the **mecA gene**, which encodes an altered Penicillin-Binding Protein (**PBP2a**). This altered protein has a very low affinity for almost all beta-lactam antibiotics. By definition, MRSA strains are resistant to all penicillins, cephalosporins (except 5th generation), carbapenems, and monobactams. Furthermore, MRSA isolates frequently carry additional resistance determinants on the same mobile genetic element (SCCmec), making them inherently **multidrug-resistant (MDR)** to other classes like aminoglycosides, macrolides, and tetracyclines. **2. Why the other options are incorrect:** * **Option A:** Isoxazolyl penicillins (e.g., Methicillin, Oxacillin, Cloxacillin) are the very drugs MRSA is resistant to. They are ineffective because they cannot bind to PBP2a. * **Option C:** While Vancomycin was historically the "gold standard," the emergence of **VRSA** (Vancomycin-Resistant *S. aureus*) and **VISA** (Vancomycin-Intermediate *S. aureus*) means Vancomycin is no longer universally effective against all MRSA strains. * **Option D:** MRSA is not necessarily more virulent than Methicillin-Sensitive *S. aureus* (MSSA). Its danger lies in its **resistance profile**, which makes infections harder to treat, leading to higher morbidity and mortality, rather than an inherent increase in toxin production or invasiveness. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Test for MRSA:** Cefoxitin Disc Diffusion test (better inducer of the mecA gene than oxacillin). * **Treatment of Choice:** Vancomycin (for sensitive strains) or Linezolid/Daptomycin. * **Exception to Beta-lactam Resistance:** 5th generation cephalosporins (**Ceftaroline** and Ceftobiprole) are effective against MRSA. * **Screening:** Nasal swabs are used to detect carriers.

Question 53: All of the following statements about Penicillin resistance are true, EXCEPT?

A. Beta-lactamase production is the most common mechanism of resistance.
B. Alteration in target PBPs is an important resistance mechanism in Gram-negative bacteria. (Correct Answer)
C. Alteration in permeability/penetration of antibiotic causes resistance only in Gram-negative bacteria.
D. Beta-lactamase production causes resistance in both Gram-positive and Gram-negative bacteria.

Explanation: **Explanation** The question asks for the **incorrect** statement regarding penicillin resistance. **1. Why Option B is the Correct Answer (The Incorrect Statement):** While alteration in **Penicillin-Binding Proteins (PBPs)** is a known mechanism, it is the **primary** mechanism of resistance in **Gram-positive bacteria**, most notably *Streptococcus pneumoniae* and Methicillin-resistant *Staphylococcus aureus* (MRSA). In Gram-negative bacteria, while PBP changes can occur, the predominant and most clinically significant mechanisms are beta-lactamase production and decreased permeability (porin loss). **2. Analysis of Other Options:** * **Option A:** Beta-lactamase production (enzymatic degradation) is indeed the **most common** mechanism of resistance across the bacterial spectrum, particularly in Staphylococci and various Gram-negative rods. * **Option C:** Gram-negative bacteria possess an **outer membrane** with porin channels. Resistance via decreased permeability (porin mutation) is unique to Gram-negatives because Gram-positive bacteria lack this outer membrane, making their peptidoglycan layer directly accessible. * **Option D:** Both groups utilize beta-lactamases. Gram-positives (like *S. aureus*) secrete exoenzymes into the medium, while Gram-negatives (like *E. coli*) produce enzymes that remain in the **periplasmic space**, making them highly efficient. **High-Yield Clinical Pearls for NEET-PG:** * **MRSA Mechanism:** Encoded by the **mecA gene**, which produces **PBP2a**, a target with low affinity for almost all beta-lactams. * **Pneumococcal Resistance:** Occurs via "mosaic genes" that alter PBPs through transformation. * **ESBLs:** Extended-spectrum beta-lactamases are a major concern in Gram-negative infections (e.g., *Klebsiella*), often requiring Carbapenems for treatment.

Question 54: What is the antibiotic of choice for Stenotrophomonas maltophilia infection?

A. Ampicillin
B. Trimethoprim-sulfamethoxazole (TMP-SMX) (Correct Answer)
C. Penicillin
D. Ciprofloxacin

Explanation: **Explanation:** *Stenotrophomonas maltophilia* is a non-fermenting, Gram-negative bacillus increasingly associated with nosocomial infections, particularly in immunocompromised patients and those on long-term mechanical ventilation. **1. Why Trimethoprim-sulfamethoxazole (TMP-SMX) is correct:** TMP-SMX is the **drug of choice** because *S. maltophilia* is inherently resistant to a vast majority of broad-spectrum antibiotics, including most carbapenems. TMP-SMX demonstrates the most consistent in-vitro activity and clinical efficacy against this pathogen. It works by inhibiting sequential steps in the bacterial folic acid synthesis pathway. **2. Why the other options are incorrect:** * **Ampicillin & Penicillin (Options A & C):** *S. maltophilia* is intrinsically resistant to almost all beta-lactams. It produces two potent chromosomal beta-lactamases: **L1** (a metallo-beta-lactamase that hydrolyzes carbapenems) and **L2** (a serine cephalosporinase). * **Ciprofloxacin (Option D):** While some strains may show susceptibility to fluoroquinolones (like Levofloxacin), resistance develops rapidly during monotherapy. It is not considered the primary treatment of choice compared to TMP-SMX. **Clinical Pearls for NEET-PG:** * **Carbapenem Resistance:** A high-yield fact is that *S. maltophilia* is **intrinsically resistant to Imipenem/Meropenem** due to the L1 metallo-beta-lactamase. * **Risk Factors:** Prior use of broad-spectrum antibiotics (especially carbapenems) and presence of indwelling devices (CVCs). * **Alternative Therapy:** For patients allergic to sulfa drugs, **Levofloxacin**, **Minocycline**, or **Ceftazidime-avibactam** are considered alternative options. * **Culture Characteristics:** It is oxidase-negative and catalase-positive.

Question 55: Which statement is NOT TRUE regarding antibiotic resistance in bacteria?

A. The most common mechanism is the production of antibiotic-destroying enzymes.
B. Lack of a target binding site may be a mechanism of resistance in some enterococci against vancomycin.
C. Plasmid-mediated resistance is transmitted only vertically. (Correct Answer)
D. Target binding site alteration is the mechanism in some pneumococci.

Explanation: ### Explanation **1. Why Option C is the Correct Answer (The "Not True" Statement):** Plasmid-mediated resistance is characterized by its ability to be transmitted both **vertically** (from parent cell to daughter cells during binary fission) and **horizontally** (between different bacteria, often across species). Horizontal gene transfer (HGT) occurs via **conjugation** (the most common method involving sex pili), transformation, or transduction. This rapid horizontal spread is what makes plasmid-mediated resistance a significant public health threat. **2. Analysis of Other Options:** * **Option A:** This is **True**. The production of enzymes (e.g., **Beta-lactamases** which hydrolyze the beta-lactam ring or aminoglycoside-modifying enzymes) is statistically the most common mechanism of bacterial resistance. * **Option B:** This is **True**. In Vancomycin-Resistant Enterococci (**VRE**), the terminal D-Ala-D-Ala of the peptidoglycan precursor is replaced by **D-Ala-D-Lactate** or D-Ala-D-Serine. This results in a lack of a high-affinity binding site for vancomycin. * **Option D:** This is **True**. Resistance in *Streptococcus pneumoniae* to penicillin is not due to beta-lactamase production but due to **alterations in Penicillin-Binding Proteins (PBPs)**, which reduces the drug's binding affinity. ### High-Yield Clinical Pearls for NEET-PG: * **R-Plasmids:** These are extrachromosomal DNA molecules that often carry multiple resistance genes (multidrug resistance). * **MRSA Mechanism:** Resistance in Methicillin-resistant *Staphylococcus aureus* is due to the **mecA gene**, which encodes an altered PBP (**PBP2a**). * **Transposons ("Jumping Genes"):** These are DNA sequences that can move from a plasmid to a chromosome or vice versa, further facilitating the spread of resistance. * **Efflux Pumps:** A common mechanism for tetracycline and fluoroquinolone resistance where the bacteria actively pump the drug out of the cell.

Question 56: Which of the following is NOT true of transferable drug resistance?

A. Multiple drug resistance simultaneously
B. Virulence of bacteria is unchanged
C. Can be prevented by drug combinations (Correct Answer)
D. Can occur to a very high degree

Explanation: **Explanation:** Transferable drug resistance is primarily mediated by **R-plasmids** (extrachromosomal DNA) through processes like **conjugation**. Understanding its mechanism is crucial for distinguishing it from mutational resistance. **Why Option C is the correct answer (The False Statement):** Drug combinations (e.g., using Rifampicin and Isoniazid for TB) are highly effective at preventing **mutational resistance**, as the probability of a bacterium developing spontaneous mutations against two drugs simultaneously is mathematically negligible. However, drug combinations **cannot prevent transferable resistance**. This is because R-plasmids often carry multiple resistance genes (r-determinants) on a single plasmid. When a bacterium transfers this plasmid to another, the recipient instantly acquires resistance to all those drugs at once, regardless of the combination used. **Analysis of Incorrect Options:** * **Option A:** True. R-plasmids frequently carry genes for resistance to several unrelated antibiotics (e.g., sulfonamides, tetracycline, chloramphenicol), leading to **multidrug resistance (MDR)** in a single transfer event. * **Option B:** True. The acquisition of an R-plasmid generally affects the antibiotic sensitivity profile but **does not alter the virulence** or pathogenicity of the bacteria. * **Option C:** True. Transferable resistance can reach a **very high degree** because plasmids can exist in multiple copies within a cell, and the transfer can spread rapidly through a bacterial population (horizontal gene transfer). **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Conjugation is the most common method for transferable resistance in Gram-negative bacilli (e.g., *E. coli*, *Shigella*). * **Mutational vs. Transferable:** Mutational resistance is usually low-grade, specific to one drug, and spreads vertically. Transferable resistance is high-grade, involves multiple drugs, and spreads horizontally. * **Transposons:** Often called "jumping genes," these play a key role in moving resistance genes between plasmids and chromosomes.

Question 57: Which medium is primarily used for antibiotic sensitivity testing?

A. CLED agar
B. Chocolate agar
C. Mueller-Hinton agar (Correct Answer)
D. Salt milk agar

Explanation: **Explanation:** **Mueller-Hinton Agar (MHA)** is the gold standard medium for routine antibiotic susceptibility testing (AST) using the Kirby-Bauer disk diffusion method. It is preferred because it is a **non-selective, non-differential** medium that allows for the growth of most non-fastidious pathogens. Its specific formulation contains low levels of thymine, thymidine, and sulfonamide inhibitors, which ensures accurate results for sulfonamides and trimethoprim. Additionally, its loose agar concentration allows for better diffusion of antibiotics, resulting in clear, reproducible zones of inhibition. **Analysis of Incorrect Options:** * **CLED Agar (Cysteine-Lactose-Electrolyte-Deficient):** Primarily used for urinary tract infections (UTI). It prevents the swarming of *Proteus* species and supports the growth of common urinary pathogens. * **Chocolate Agar:** An enriched medium containing lysed red blood cells. It is used for fastidious organisms like *Haemophilus influenzae* and *Neisseria* species, but not for standard AST. * **Salt Milk Agar:** A selective medium used specifically for the isolation of *Staphylococcus aureus*, utilizing high salt concentration to inhibit other flora. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Depth:** MHA must be poured to a depth of exactly **4 mm**. If it is too thin, zones of inhibition will be falsely large; if too thick, zones will be falsely small. * **pH Requirement:** The ideal pH is **7.2 to 7.4**. * **Supplementation:** For fastidious organisms like *Streptococcus pneumoniae*, MHA is supplemented with **5% sheep blood**. * **Cation Concentration:** Variations in Calcium and Magnesium levels in MHA can affect results for Aminoglycosides and Tetracyclines against *Pseudomonas aeruginosa*.

Question 58: Why is urethral Mycoplasma genitalium infection often resistant to azithromycin treatment?

A. It produces beta-lactamase enzymes
B. It acquires mutations in the 23S rRNA gene (Correct Answer)
C. It has intrinsic antimicrobial efflux pumps
D. It forms biofilms in the urethra

Explanation: ***Correct: It acquires mutations in the 23S rRNA gene*** - **Azithromycin** is a macrolide antibiotic that binds to the bacterial **23S ribosomal RNA (rRNA)** within the 50S ribosomal subunit, inhibiting protein synthesis. - *Mycoplasma genitalium* develops resistance through **point mutations** at positions 2058 and 2059 in the 23S rRNA gene, preventing effective drug binding to the ribosome. - These mutations are the **primary mechanism** of azithromycin resistance in *M. genitalium* and are increasingly prevalent, making treatment challenging. *Incorrect: It produces beta-lactamase enzymes* - **Beta-lactamase enzymes** hydrolyze the beta-lactam ring and confer resistance to **beta-lactam antibiotics** (penicillins, cephalosporins). - **Azithromycin is a macrolide**, not a beta-lactam, so beta-lactamase production is irrelevant to its mechanism of action. - Additionally, *Mycoplasma* species **lack a cell wall**, making them inherently resistant to beta-lactam antibiotics regardless of enzyme production. *Incorrect: It has intrinsic antimicrobial efflux pumps* - While **efflux pumps** can contribute to antibiotic resistance in various bacteria by actively expelling drugs from the cell, this is **not the primary mechanism** of azithromycin resistance in *M. genitalium*. - The dominant and clinically significant resistance mechanism is **chromosomal mutations in the 23S rRNA gene**, not efflux-mediated resistance. *Incorrect: It forms biofilms in the urethra* - **Biofilm formation** can protect bacteria from antibiotics and immune responses, contributing to persistent infections. - However, **biofilm formation is not the main mechanism** of azithromycin resistance in *M. genitalium*; the primary cause is **specific ribosomal target-site mutations** that prevent drug binding.

Question 59: Which of the following statements about antibiotic resistance in N. gonorrhoeae is FALSE?

A. Ceftriaxone resistance typically involves alterations in the penA gene
B. Resistance to fluoroquinolones is often due to mutations in gyrA and parC genes
C. Spectinomycin resistance remains extremely rare globally
D. Tetracycline resistance is primarily mediated by beta-lactamase production (Correct Answer)

Explanation: ***Tetracycline resistance is primarily mediated by beta-lactamase production*** - This statement is **FALSE**. Beta-lactamases (such as TEM-1 and TEM-135) in *N. gonorrhoeae* confer resistance to **penicillins and related beta-lactam antibiotics**, not tetracyclines. - **Tetracycline resistance** in *N. gonorrhoeae* is mediated by two distinct mechanisms: **plasmid-borne TetM determinants** (conferring high-level resistance through ribosomal protection) and **chromosomal mutations** (affecting mtrR, penB, and rpsJ genes, leading to increased efflux or altered ribosomal targets). - Beta-lactamase production and tetracycline resistance are independent resistance mechanisms. *Ceftriaxone resistance typically involves alterations in the penA gene* - This is **TRUE**. Ceftriaxone resistance in *N. gonorrhoeae* is primarily associated with **mosaic _penA_ alleles** encoding altered penicillin-binding protein 2 (PBP2). - These mosaic alleles result in decreased affinity of PBP2 for cephalosporins, reducing drug effectiveness. - Additional mechanisms include mtrR mutations (increasing efflux) and penB mutations (decreasing permeability). *Resistance to fluoroquinolones is often due to mutations in gyrA and parC genes* - This is **TRUE**. Fluoroquinolone resistance in *N. gonorrhoeae* primarily results from mutations in the **quinolone resistance-determining regions (QRDRs)** of **_gyrA_** and **_parC_** genes. - These genes encode subunits of DNA gyrase and topoisomerase IV respectively, the primary targets of fluoroquinolones. - The most common mutation is S91F in GyrA, with additional mutations in ParC contributing to higher-level resistance. *Spectinomycin resistance remains extremely rare globally* - This is **TRUE**. Spectinomycin resistance in *N. gonorrhoeae* remains **extremely rare worldwide**, with only sporadic case reports. - Resistance is mediated by mutations in the **16S rRNA gene** (particularly at position 1192), but this mechanism has not become widespread. - Spectinomycin remains a valuable alternative therapy, particularly for patients with cephalosporin allergies or in areas with cephalosporin resistance.

Question 60: Which bacterial component is critical for the antibiotic resistance of N. gonorrhoeae to penicillin?

A. Beta-lactamase enzyme
B. Ribosomal protection proteins
C. Efflux pump system
D. Altered PBP2 (penA gene mutations) (Correct Answer)

Explanation: ***Altered PBP2 (penA gene mutations)*** - **Mutations in the *penA* gene** lead to changes in **penicillin-binding protein 2 (PBP2)**, reducing its affinity for penicillin and other beta-lactam antibiotics. - This reduced binding affinity prevents penicillin from effectively inhibiting **cell wall synthesis**, allowing *N. gonorrhoeae* to resist its bactericidal effects. *Beta-lactamase enzyme* - While beta-lactamase (specifically **penicillinase**) produced by some *N. gonorrhoeae* strains can **hydrolyze the beta-lactam ring** of penicillin, it is not the *critical* and most prevalent mechanism for **high-level penicillin resistance** in current strains. - The evolution of resistance has largely shifted from beta-lactamase production to **PBP mutations**. *Ribosomal protection proteins* - These proteins are primarily associated with resistance to **macrolide antibiotics** and tetracyclines, not penicillins. - They work by binding to the ribosome and **preventing antibiotic interference** with protein synthesis. *Efflux pump system* - Efflux pumps contribute to resistance by actively **expelling antibiotics** from the bacterial cell, thereby preventing them from reaching their intracellular targets. - While efflux pumps can play a role in **multi-drug resistance**, they are not the primary mechanism for penicillin resistance in *N. gonorrhoeae*.

Practice by Chapter

Mechanisms of Antimicrobial Resistance

Practice Questions

Beta-lactamase Producing Organisms

Practice Questions

Methicillin-Resistant Staphylococcus aureus

Practice Questions

Vancomycin-Resistant Enterococci

Practice Questions

Carbapenem-Resistant Enterobacteriaceae

Practice Questions

Multi-drug Resistant Tuberculosis

Practice Questions

Antimicrobial Stewardship

Practice Questions

Detection of Antimicrobial Resistance

Practice Questions

Global Surveillance of Resistance

Practice Questions

New Antimicrobial Development

Practice Questions

Alternative Approaches to Antimicrobial Therapy

Practice Questions

One Health Approach to Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free